So inhaled steroids slow the rate of decline of FEV(1) in patients with COPD after all?

Burge P S; Lewis S A
November 2003
Thorax;Nov2003, Vol. 58 Issue 11, p911
Academic Journal
No abstract available.


Related Articles

  • New study allays fear over inhaled steroids. Pedder, Cato // Pulse;11/10/2003, Vol. 63 Issue 45, p17 

    Reports on the results of the study examining the effects of inhaled corticosteroids in patients with asthma or chronic obstructive pulmonary disease (COPD) in the U.S. Tendency of COPD to lead to decrease in bone mineral density; Indication that the inhaled steroids slow lung function decline...

  • CITATIONS AND CLINICIANS' NOTES: CHRONIC OBSTRUCTIVE DISEASE.  // Current Medical Literature: Respiratory Medicine;2004, Vol. 18 Issue 3, p65 

    The article presents an understanding of chronic obstructive disease (COPD). Inhaled steroids reduce the rate of exacerbations and slow the rate of decline of the quality of life. The paper "Standards for the Diagnosis and Treatment of Patients with COPD: a summary of the ATS/ERS position...

  • Pulmonary.  // Africa Health;Jan2012, Vol. 34 Issue 2, p50 

    The article highlights several medical studies related to pulmonary. A study reveals that on multidetector computed tomography (CT) the number of airways was reduced in patients with stages one to four chronic obstructive pulmonary disease (COPD). Another study shows a high degree of variability...

  • Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Sutherland E R; Allmers H; Ayas N T; Venn A J; Martin R J; Sutherland, E R; Allmers, H; Ayas, N T; Venn, A J; Martin, R J // Thorax;Nov2003, Vol. 58 Issue 11, p937 

    Background: Chronic obstructive pulmonary disease (COPD) is a syndrome of chronic progressive airflow limitation which occurs as a result of chronic inflammation of the airways and lung parenchyma. However, the role of inhaled corticosteroids in the treatment of COPD is...

  • Inhaled Steroids Modulate Extracellular Matrix Composition in Bronchial Biopsies of COPD Patients: A Randomized, Controlled Trial Kunz, Lisette I. Z.; Strebus, Jolanda; Budulac, Simona E.; Lapperre, Therese S.; Sterk, Peter J.; Postma, Dirkje S.; Mauad, Thais; Timens, Wim; Hiemstra, Pieter S. // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Rationale: Smoking and inflammation contribute to the pathogenesis of chronic obstructive pulmonary disease (COPD), which involves changes in extracellular matrix. This is thought to contribute to airway remodeling and airflow obstruction. We have previously observed that long-term treatment...

  • Long-Acting β-Agonists in the Treatment of Acute Exacerbations of COPD. Cazzola, M.; Matera, M.G.; D'Amato, M.; Noschese, P.; Califano, C.; Di Perna, F.; Terzano, C.; D'Amato, G. // Clinical Drug Investigation;2002, Vol. 22 Issue 6, p369 

    Objective: To evaluate the acute bronchodilating effect of cumulative doses of formoterol administered via TurbuhalerÅ’ or salmeterol administered via pressurised metered-dose inhaler (pMDI) in patients with mild acute exacerbations of chronic obstructive pulmonary disease (COPD) to determine...

  • Should Inhaled Corticosteroids be Used in the Long Term Treatment of Chronic Obstructive Pulmonary Disease? Burge, S. // Drugs;Aug2001, Vol. 61 Issue 11, p1535 

    Chronic obstructive pulmonary disease (COPD) is a progressive disease with alveolar destruction (emphysema) and bronchiolar fibrosis (obstructive bronchitis) in variable proportions. Reducing disease progression, as assessed by forced expiratory volume in 1 second (FEV) decline, health-related...

  • What effect do inhaled steroids have on delaying the progression of COPD? Hansen, Laura; Havemann, James; Burroughs, Martha // Journal of Family Practice;Oct2004, Vol. 53 Issue 10, p835 

    The annual rate of decline in forced expiratory volume for 1 second (FEV1) has been an objective measure for progression of chronic obstructive pulmonary disease (COPD). This article seeks to determine the impact of inhaled corticosteroids on FEV1 decline and on the progression of COPD.

  • Comparison of the lung function change in patients with COPD and bronchial asthma before and after treatment with budesonide/formoterol. Gao, Shao-Yong; Huang, Jian-Qiang; Luo, Yi-Feng; Li, Zhi-Ping; Xie, Can-Mao; Guo, Yu-Biao // Journal of Thoracic Disease;Dec2012, Vol. 4 Issue 6, p583 

    Objective: This study investigated the rapid onset of bronchodilation effect and compared lung function changes following budesonide/formoterol (Symbicort Turbuhaler®) inhalation in Chinese patients with moderate-severe chronic obstructive pulmonary disease (COPD) and bronchial asthma....

  • Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Burge P S; Calverley P M A; Jones P W; Spencer S; Anderson J A // Thorax;Aug2003, Vol. 58 Issue 8, p654 

    BACKGROUND: A trial of corticosteroids has been recommended for all patients with chronic obstructive pulmonary disease (COPD), with the subsequent "response" determining the treatment selected. This approach assumes that patients can be reliably divided into responder and non-responder groups....


Read the Article


Sign out of this library

Other Topics